Sorrento Therapeutics Inc (NASDAQ:SRNE)

1.45
Delayed Data
As of May 24
 -0.13 / -8.23%
Today’s Change
1.15
Today|||52-Week Range
11.07
-68.82%
Year-to-Date
Kamada (KMDA) Reports Q1 Loss, Lags Revenue Estimates
May 17 / Zacks.com - Paid Partner Content
Aravive (ARAV) Reports Q1 Loss, Tops Revenue Estimates
May 12 / Zacks.com - Paid Partner Content
Albireo Pharma (ALBO) Reports Q1 Loss, Lags Revenue Estimates
May 16 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close1.58
Today’s open1.54
Day’s range1.43 - 1.54
Volume375,177
Average volume (3 months)8,927,062
Market cap$618.4M
Data as of 4:00pm ET, 05/24/2022

Growth & Valuation

Earnings growth (last year)-11.89%
Earnings growth (this year)--
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+32.31%
P/E ratioNM
Price/Sales25.91
Price/Book6.35

Competitors

 Today’s
change
Today’s
% change
CHRSCoherus BioSciences ...-0.32-4.01%
QUREUniqure NV+0.87+6.51%
SGMOSangamo Therapeutics...-0.46-11.47%
ANABAnaptysBio Inc-0.54-2.63%
Data as of 4:00pm ET, 05/24/2022

Financials

Last reporting dateMay 25, 2022
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$52.9M
Annual profit (last year)-$428.3M
Net profit margin-809.63%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
San Diego, California

Forecasts